Clinical Trial: Study to Assess the Efficacy and Safety of Rina-S Plus Standard of Care Compared to Standard of Care for Maintenance Treatment of Participants With Recurrent Platinum-sensitive Ovarian Cancer After Second-line (2L) Platinum-based Doublet Chemotherapy

U.S., Nov. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07225270) titled 'Study to Assess the Efficacy and Safety of Rina-S Plus Standard of Care Compared to Standard of Care for Maintenance Treatment of Participants With Recurrent Platinum-sensitive Ovarian Cancer After Second-line (2L) Platinum-based Doublet Chemotherapy' on Nov. 04.

Brief Summary: This Phase 3 study will be conducted in different countries around the world with up to about 528 participants.

The purpose of this study is to evaluate how well Rina-S works against ovarian cancer in combination (with) available standard of care therapy that is already approved and used for ovarian cancer.

Participants will receive either Rina-S monotherapy...